| Irb Medical Equipment Llc | |
| 21651 Melrose Ave, Southfield, Michigan 48075 | |
| (248) 353-2468 |
| Name | Irb Medical Equipment Llc |
|---|---|
| Organization Name | Irb Medical Equipment Llc |
| Location | 21651 Melrose Ave, Southfield, Michigan 48075 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (248) 353-2468 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mood disorders, including depression, are the most common comorbid conditions in individuals with epilepsy, but the cause remains unclear, according to a latest study by researchers at Columbia University's Mailman School of Public Health and Rutgers University.
A foundation that funds research that examines the environmental causes of breast cancer has awarded a grant to a post-doctoral associate at the University of Rochester Medical Center.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
› Verified 2 days ago
| NPI Number | 1295150308 |
| Organization Name | IRB MEDICAL EQUIPMENT LLC |
| Doing Business As | HART MEDICAL EQUIPMENT |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 21651 Melrose Ave, Southfield, MI 48075 |
| Phone Number | 248-353-2468 |
News Archive
Mood disorders, including depression, are the most common comorbid conditions in individuals with epilepsy, but the cause remains unclear, according to a latest study by researchers at Columbia University's Mailman School of Public Health and Rutgers University.
A foundation that funds research that examines the environmental causes of breast cancer has awarded a grant to a post-doctoral associate at the University of Rochester Medical Center.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
› Verified 2 days ago
| NPI Number | 1588654321 |
| Organization Name | HENRY FORD HEALTH SYSTEM |
| Doing Business As | HENRY FORD HEALTH PRODUCTS |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 21651 Melrose Ave, Southfield, MI 48075 |
| Phone Number | 248-353-2468 |
News Archive
Mood disorders, including depression, are the most common comorbid conditions in individuals with epilepsy, but the cause remains unclear, according to a latest study by researchers at Columbia University's Mailman School of Public Health and Rutgers University.
A foundation that funds research that examines the environmental causes of breast cancer has awarded a grant to a post-doctoral associate at the University of Rochester Medical Center.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
› Verified 2 days ago
News Archive
Mood disorders, including depression, are the most common comorbid conditions in individuals with epilepsy, but the cause remains unclear, according to a latest study by researchers at Columbia University's Mailman School of Public Health and Rutgers University.
A foundation that funds research that examines the environmental causes of breast cancer has awarded a grant to a post-doctoral associate at the University of Rochester Medical Center.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The U.S. Food and Drug Administration (FDA) has approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
› Verified 2 days ago
Cvs Pharmacy #17285 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 30333 Southfield Rd, Southfield, Michigan 48076 Phone: (248) 430-0063 | |
Irb Medical Equipment Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21651 Melrose Ave, Southfield, Michigan 48075 Phone: (248) 353-2468 | |
Cvs Pharmacy #08143 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 26026 W 12 Mile Rd, Southfield, Michigan 48034 Phone: (248) 350-0280 | |
Cvs Pharmacy #08233 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 23881 Greenfield Mt. Vernonrd, Southfield, Michigan 48075 Phone: (247) 424-5002 | |
Rt Specialists Corporation Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15565 Northland Dr E, Southfield, Michigan 48075 Phone: (248) 461-2052 |